Cargando…
Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis
BACKGROUND & AIMS: Acute liver failure (ALF) is a condition with high mortality and morbidity, characterized by glutathione depletion, oxidative stress, and mitochondrial dysfunction. Ferroptosis may be involved in ALF. Indeed, emerging studies have shown that ferroptosis plays a significant rol...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046809/ https://www.ncbi.nlm.nih.gov/pubmed/35202887 http://dx.doi.org/10.1016/j.jcmgh.2022.02.009 |
_version_ | 1784695593767010304 |
---|---|
author | Huang, Sha Wang, Yuhua Xie, Shunwen Lai, Yuqi Mo, Chan Zeng, Ting Kuang, Shanshan Deng, Guanghui Zhou, Chuying Chen, Yuyao Huang, Shaohui Gao, Lei Lv, Zhiping |
author_facet | Huang, Sha Wang, Yuhua Xie, Shunwen Lai, Yuqi Mo, Chan Zeng, Ting Kuang, Shanshan Deng, Guanghui Zhou, Chuying Chen, Yuyao Huang, Shaohui Gao, Lei Lv, Zhiping |
author_sort | Huang, Sha |
collection | PubMed |
description | BACKGROUND & AIMS: Acute liver failure (ALF) is a condition with high mortality and morbidity, characterized by glutathione depletion, oxidative stress, and mitochondrial dysfunction. Ferroptosis may be involved in ALF. Indeed, emerging studies have shown that ferroptosis plays a significant role in ALF. However, the mechanism of ferroptosis in hepatocytes during ALF remains unknown. METHODS: Hepatic-specific transforming growth factor β receptor 1 knockout (TGFβr1(Δhep-CKO)) mice and nuclear factor erythroid 2-related factor 2 knockout (Nrf2(-/-)) mice were generated and subjected to ALF. Electron microscopy was used to detect mitochondrial and other cell substructure changes during ALF. RESULTS: In this study, we noticed that lipopolysaccharide (LPS)/D-galactosamine (D-GalN) induced caspases-mediated apoptosis as current research reported, we also found lipid peroxidation, reactive oxygen species accumulation, and glutathione, co-enzyme Q10 system inhibition mediated ferroptosis during LPS/D-GalN-induced ALF. Rescue studies have shown that ferrostatin-1 (Fer-1) and deferoxamine mesylate (DFOM), the inhibitor of ferroptosis, could alleviate LPS/D-GalN-induced ALF. In addition, we noticed that TGFβ1 was increased during ALF, while ALF was relieved in TGFβr1(Δhep-CKO) mice. We also noticed that liver TGFβr1 deficiency alleviated LPS/D-GalN-induced apoptosis and ferroptosis by affecting the phosphorylation of glycogen synthase kinase 3β and Nrf2, a key antioxidant factor, by up-regulating the levels of glutathione peroxidase 4 (GPX4), glutamine antiporter xCT (XCT), dihydroorotate dehydrogenase (DHODH), and ferroptosis suppressor protein 1 (FSP1), and down-regulating transferrin receptor (TFR), prostaglandin-endoperoxide synthase (Ptgs2), chaC glutathione specific gamma-glutamylcyclotransferase 1 (CHAC1), and cytochrome P450 reductase (POR) expression. The further supplemental experiment showed that ferroptosis was aggravated significantly in Nrf2(-/-) mice compared with its wild-type controls and reversed by ferrostatin-1. CONCLUSIONS: This study shows that TGFβr1 plays a critical role in mediating LPS/D-GalN-induced ALF by promoting apoptosis and ferroptosis. |
format | Online Article Text |
id | pubmed-9046809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90468092022-04-29 Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis Huang, Sha Wang, Yuhua Xie, Shunwen Lai, Yuqi Mo, Chan Zeng, Ting Kuang, Shanshan Deng, Guanghui Zhou, Chuying Chen, Yuyao Huang, Shaohui Gao, Lei Lv, Zhiping Cell Mol Gastroenterol Hepatol Original Research BACKGROUND & AIMS: Acute liver failure (ALF) is a condition with high mortality and morbidity, characterized by glutathione depletion, oxidative stress, and mitochondrial dysfunction. Ferroptosis may be involved in ALF. Indeed, emerging studies have shown that ferroptosis plays a significant role in ALF. However, the mechanism of ferroptosis in hepatocytes during ALF remains unknown. METHODS: Hepatic-specific transforming growth factor β receptor 1 knockout (TGFβr1(Δhep-CKO)) mice and nuclear factor erythroid 2-related factor 2 knockout (Nrf2(-/-)) mice were generated and subjected to ALF. Electron microscopy was used to detect mitochondrial and other cell substructure changes during ALF. RESULTS: In this study, we noticed that lipopolysaccharide (LPS)/D-galactosamine (D-GalN) induced caspases-mediated apoptosis as current research reported, we also found lipid peroxidation, reactive oxygen species accumulation, and glutathione, co-enzyme Q10 system inhibition mediated ferroptosis during LPS/D-GalN-induced ALF. Rescue studies have shown that ferrostatin-1 (Fer-1) and deferoxamine mesylate (DFOM), the inhibitor of ferroptosis, could alleviate LPS/D-GalN-induced ALF. In addition, we noticed that TGFβ1 was increased during ALF, while ALF was relieved in TGFβr1(Δhep-CKO) mice. We also noticed that liver TGFβr1 deficiency alleviated LPS/D-GalN-induced apoptosis and ferroptosis by affecting the phosphorylation of glycogen synthase kinase 3β and Nrf2, a key antioxidant factor, by up-regulating the levels of glutathione peroxidase 4 (GPX4), glutamine antiporter xCT (XCT), dihydroorotate dehydrogenase (DHODH), and ferroptosis suppressor protein 1 (FSP1), and down-regulating transferrin receptor (TFR), prostaglandin-endoperoxide synthase (Ptgs2), chaC glutathione specific gamma-glutamylcyclotransferase 1 (CHAC1), and cytochrome P450 reductase (POR) expression. The further supplemental experiment showed that ferroptosis was aggravated significantly in Nrf2(-/-) mice compared with its wild-type controls and reversed by ferrostatin-1. CONCLUSIONS: This study shows that TGFβr1 plays a critical role in mediating LPS/D-GalN-induced ALF by promoting apoptosis and ferroptosis. Elsevier 2022-02-21 /pmc/articles/PMC9046809/ /pubmed/35202887 http://dx.doi.org/10.1016/j.jcmgh.2022.02.009 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Huang, Sha Wang, Yuhua Xie, Shunwen Lai, Yuqi Mo, Chan Zeng, Ting Kuang, Shanshan Deng, Guanghui Zhou, Chuying Chen, Yuyao Huang, Shaohui Gao, Lei Lv, Zhiping Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis |
title | Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis |
title_full | Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis |
title_fullStr | Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis |
title_full_unstemmed | Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis |
title_short | Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis |
title_sort | hepatic tgfβr1 deficiency attenuates lipopolysaccharide/d-galactosamine–induced acute liver failure through inhibiting gsk3β–nrf2–mediated hepatocyte apoptosis and ferroptosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046809/ https://www.ncbi.nlm.nih.gov/pubmed/35202887 http://dx.doi.org/10.1016/j.jcmgh.2022.02.009 |
work_keys_str_mv | AT huangsha hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT wangyuhua hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT xieshunwen hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT laiyuqi hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT mochan hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT zengting hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT kuangshanshan hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT dengguanghui hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT zhouchuying hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT chenyuyao hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT huangshaohui hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT gaolei hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis AT lvzhiping hepatictgfbr1deficiencyattenuateslipopolysaccharidedgalactosamineinducedacuteliverfailurethroughinhibitinggsk3bnrf2mediatedhepatocyteapoptosisandferroptosis |